Supporting patients who aren’t ready to quit smoking? Explore harm reduction strategies in our quality standard⬇️ https://t.co/f8JBbC9atX #Stoptober #StopSmoking

Today’s recommendation has also been welcomed by professor Yvonne Gilleece, chair of @BritishHIVAssoc.

Learn why people who are blind and have low vision are calling Waymo’s fully autonomous driving technology a ‘game changer.’

Cabotegravir is administered as an injection every two months in specialist sexual health clinics. This approach addresses a critical gap for people who cannot have daily medication, with up to 1,000 people expected to benefit in England per year.

NICE approves first HIV prevention injection for those who can't have a daily PrEP tablet. Cabotegravir offers a new PrEP option for high-risk individuals, used alongside safer sex practices: https://t.co/zUegv7VtcJ

🆕NICE has recommended a standardised approach for rehabilitation, to address the variation of care experienced by millions of people with chronic neurological conditions. Learn more⬇️ https://t.co/8mWu3yZo6t

Four AI technologies recommended to identify hidden spinal fractures on routine scans in final guidance. These tools could detect thousands of undiagnosed cases, enabling earlier treatment and preventing future fractures while saving NHS resources: https://t.co/Fd2Fn8toGV

Quitting smoking is the best thing you can do for your health. When you stop, you’ll experience health benefits almost immediately! It’s never too late to quit. 💪

📱When children's mental health services faced surging demand, NHS_ELFT adopted a digital solution. Dale Greenwood explains how NICE healthtech guidance helped his trust implement a digital therapy app for children with anxiety⬇️ https://t.co/AUPTQlFAXg #WorldMentalHealthDay

How NICE is opening pathways to digital health technologies for the NHS. Following her appearance at #HETT25, programme director Sarah Byron tells us why the #10YearHealthPlan is a game changer for healthtech and how we’re driving the changes at NICE⬇️ https://t.co/fsTLwMwTrP

🆕New treatment option to prevent hereditary angioedema attacks, a rare condition causing unpredictable, painful swelling that can be life-threatening. For people aged 12 years and over who have 2 or more attacks a month. Learn more about garadacimab: https://t.co/urf1hEjgvj

Today's recommendation was welcomed by Debra Montague, chair of @UKALK1⬇️

People with an aggressive form of lung cancer are set to benefit after we recommended a new treatment option today. Find out more about lorlatinib: https://t.co/Bguf5HL9Lq

🎧This time on #NICEtalks we discuss recent analysis showing disparities in SGLT-2 inhibitor prescriptions for people with type 2 diabetes in England. We also explore how our new draft recommendations could increase uptake, with our expert guests⬇️ https://t.co/HSeoaCAKEk

Opinion 🗣️ The 10 year health plan is a game changer for HealthTech, writes Dr Sarah Byron, programme director for HealthTech strategy and development at the National Institute for Health and Care Excellence (NICE). https://t.co/cSHIaSYzC3

✅The solution: @NICEcomms now recommends SGLT-2 inhibitors as first-line treatment for ALL type 2 diabetes patients. With 60% of NHS diabetes spending on preventable complications, this should help close gaps and ensure equal access. Further info⬇️ https://t.co/4JrQrTq1gG

Among patients with high CVD risk, 16% of Black or Black British people were prescribed the medicines, compared with 21% of white people.

Meanwhile, only 13% of patients aged 80-89 with atherosclerotic cardiovascular disease received SGLT-2 inhibitors prescriptions compared to 32% of those aged 50-59.

Only 1 in 5 people with atherosclerotic cardiovascular disease received SGLT-2 inhibitors prescriptions, life-saving medication that protect hearts and kidneys whilst managing #T2diabetes. Men (35%) with heart failure were more likely to receive SGLT-2 inhibtors than women (23%)

🧵NICE analysis of 590,000 people conducted in 2024 reveals prescribing gaps in diabetes care. New NICE recommendations published in August will help tackle these health inequalities. 🔗 https://t.co/4JrQrTq1gG

NICE quality standards set out priority areas for quality improvement in health, public health and social care. Have your say on our updated processes in our consultation by 31 October: https://t.co/ya4af5dSKf